$6.34 Billion is the total value of GENERAL ATLANTIC, L.P.'s 30 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ENGAGESMART | $1,723,283,699 | -0.8% | 90,271,540 | 0.0% | 27.16% | +34.5% | ||
SQSP | SQUARESPACEcl a | $705,268,242 | -0.7% | 22,361,073 | 0.0% | 11.12% | +34.7% | |
HIRERIGHT | $363,162,946 | +6.6% | 32,109,898 | 0.0% | 5.72% | +44.6% | ||
ALHC | ALIGNMENT HEALTHCARE | $350,711,607 | -9.6% | 60,993,323 | 0.0% | 5.53% | +22.6% | |
ALKT | ALKAMI | $306,981,520 | +29.5% | 18,729,806 | 0.0% | 4.84% | +75.6% | |
EUROPEAN WAX CENTERcl a | $244,248,466 | -1.9% | 13,110,492 | 0.0% | 3.85% | +33.0% | ||
MOBILEYEcl a | $182,952,390 | -11.2% | 4,761,905 | 0.0% | 2.88% | +20.4% | ||
YOU | CLEAR SECUREcl a | $112,632,150 | -11.5% | 4,861,120 | 0.0% | 1.78% | +20.1% | |
GINKGO BIOWORKScl a | $60,115,007 | +39.8% | 32,319,896 | 0.0% | 0.95% | +89.8% | ||
CNTA | CENTESSA PHARMACEUTICALSsponsored ads | $59,930,453 | +60.8% | 9,681,818 | 0.0% | 0.94% | +118.2% | |
IMCR | IMMUNOCOREads | $56,962,000 | +21.3% | 950,000 | 0.0% | 0.90% | +64.5% | |
ARCE | ARCO PLATFORM LIMITEDcl a | $49,814,863 | +10.8% | 4,103,366 | 0.0% | 0.78% | +50.4% | |
HCM | HUTCHMEDsponsored ads | $48,000,000 | -7.8% | 4,000,000 | 0.0% | 0.76% | +25.1% | |
RPRX | ROYALTY PHARMA | $46,110,000 | -14.7% | 1,500,000 | 0.0% | 0.73% | +15.8% | |
FUTU | FUTUspon ads cl a | $44,172,759 | -23.4% | 1,111,544 | 0.0% | 0.70% | +3.9% | |
RISKIFIEDcl a | $25,879,490 | -13.8% | 5,324,998 | 0.0% | 0.41% | +16.9% | ||
OPEN | OPENDOOR | $25,412,506 | +128.4% | 6,321,519 | 0.0% | 0.40% | +210.9% | |
BLEND LABScl a | $18,122,247 | -4.9% | 19,132,440 | 0.0% | 0.29% | +29.4% | ||
THIRD HARMONIC BIO | $14,231,645 | +16.7% | 2,958,762 | 0.0% | 0.22% | +57.7% | ||
BUZZFEEDcl a | $3,970,564 | -55.3% | 7,862,502 | 0.0% | 0.06% | -38.8% | ||
ADAG | ADAGENEadr | $390,720 | +2.1% | 264,000 | 0.0% | 0.01% | +50.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-11
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
XP, INC | 16 | Q3 2023 | 78.5% |
ENGILITY HOLDINGS INC | 16 | Q4 2018 | 25.0% |
CHINA INDEX HOLDINGS | 16 | Q1 2023 | 2.0% |
58.COM INC | 15 | Q2 2020 | 39.3% |
ARCO PLATFORM LTD | 15 | Q3 2023 | 32.7% |
ROYALTY PHARMA | 14 | Q3 2023 | 2.2% |
KCG HOLDINGS INC | 13 | Q3 2016 | 21.8% |
FANG HOLDINGS | 13 | Q3 2019 | 13.8% |
BAZAARVOICE INC | 13 | Q2 2016 | 2.8% |
TRINET GROUP INC | 12 | Q4 2016 | 41.1% |
View GENERAL ATLANTIC, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Fang Holdings Ltd | September 25, 2023 | 11,106,440 | 16.8% |
XP Inc. | July 11, 2023 | 29,617,733 | 7.1% |
Oak Street Health, Inc.Sold out | May 02, 2023 | 0 | 0.0% |
dLocal Ltd | April 25, 2023 | 63,096,501 | 38.9% |
China Index Holdings LtdSold out | April 19, 2023 | 0 | 0.0% |
CinCor Pharma, Inc.Sold out | February 28, 2023 | 0 | 0.0% |
Alignment Healthcare, Inc. | February 13, 2023 | 60,993,323 | 32.6% |
Duolingo, Inc. | February 13, 2023 | 1,479,294 | 4.7% |
European Wax Center, Inc. | February 13, 2023 | 22,817,201 | 41.5% |
Ginkgo Bioworks Holdings, Inc. | February 13, 2023 | 32,319,896 | 2.4% |
View GENERAL ATLANTIC, L.P.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
4 | 2024-05-09 |
4 | 2024-03-15 |
SC 13G | 2024-03-15 |
SC 13D/A | 2024-03-07 |
SC 13D/A | 2024-02-16 |
13F-HR | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
View GENERAL ATLANTIC, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.